Rethinking type 2 diabetes in the workplace

Type 2 diabetes is one of the largest global health emergencies of the 21st century, and in Canada, the number of workers living with diabetes or prediabetes is expected to rise over the next decade.

In this two-page whitepaper from Novo Nordisk, learn more about type 2 diabetes and its complications, and the burden of disease for people living with diabetes.

Sign up now and gain insight into:

• The impact of type 2 diabetes in the workplace
• New medications for the treatment of diabetes
• The high cost of poorly managed diabetes for employers
• The role of employers in employee health and wellness